Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $3.0 million.

  • Kewaunee Scientific's Shares Outstanding (Diluted Average) rose 53.8% to $3.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.0 million, marking a year-over-year increase of 53.8%. This contributed to the annual value of $3.0 million for FY2025, which is 139.55% up from last year.
  • As of Q4 2025, Kewaunee Scientific's Shares Outstanding (Diluted Average) stood at $3.0 million, which was up 53.8% from $3.0 million recorded in Q3 2025.
  • Kewaunee Scientific's Shares Outstanding (Diluted Average)'s 5-year high stood at $3.0 million during Q1 2025, with a 5-year trough of $2.8 million in Q2 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $2.9 million, with a median of $2.9 million in 2023.
  • As far as peak fluctuations go, Kewaunee Scientific's Shares Outstanding (Diluted Average) soared by 433.69% in 2023, and later dropped by 13.48% in 2025.
  • Over the past 5 years, Kewaunee Scientific's Shares Outstanding (Diluted Average) (Quarter) stood at $2.8 million in 2021, then grew by 1.47% to $2.8 million in 2022, then increased by 3.57% to $2.9 million in 2023, then rose by 1.47% to $3.0 million in 2024, then increased by 0.54% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q4 2025, $3.0 million for Q3 2025, and $3.0 million during Q2 2025.